Literature DB >> 31194716

Self-Reported Infertility and Associated Pelvic Inflammatory Disease Among Women of Reproductive Age-National Health and Nutrition Examination Survey, United States, 2013-2016.

Gloria Ebelechukwu Anyalechi, Jaeyoung Hong, Kristen Kreisel, Elizabeth Torrone, Sheree Boulet1, Rachel Gorwitz, Robert D Kirkcaldy, Kyle Bernstein.   

Abstract

BACKGROUND: Sexually transmitted diseases, including chlamydia and gonorrhea, cause of pelvic inflammatory disease (PID) and infertility. We estimated the prevalence of infertility and infertility health care seeking.
METHODS: We analyzed self-reported lifetime infertility and infertility health care-seeking in women aged 18 to 49 years in the 2013 and 2015 National Health and Nutrition Examination Surveys. Weighted prevalence of infertility and infertility health care seeking, prevalence ratios (PRs), and 95% confidence intervals (CIs) were calculated.
RESULTS: Among 2626 eligible women, 13.8% had self-reported infertility (95% CI, 12.3-15.3) with higher prevalence by age: 960, 18 to 29 years (PR, 6.4%; 95% CI, 4.8-8.0); 799, 30 to 39 years (PR, 14.8%; 95% CI, 12.2-17.3); and 867, 40 to 49 years (PR, 20.8%; 95% CI, 17.2-24.4). Non-Hispanic white women (PR, 15.4%; 95% CI, 13.0-17.8; n = 904) and non-Hispanic black women (PR, 12.9%; 95% CI, 10.3-15.5; n = 575) had the highest infertility prevalences. Women reporting PID treatment (n = 122) had higher infertility prevalence (PR, 24.2%; 95% CI, 16.2-32.2) than women without PID treatment (PR, 13.3%; 95% CI, 11.6-15.0; n = 2,485), especially among 18- to 29-year-old women (PR, 3.8; 95% CI, 1.8-8.0). Of 327 women with infertility, 60.9% (95% CI, 56.1-65.8) sought health care. Women without health care insurance sought care less frequently than women with insurance.
CONCLUSIONS: In a nationally representative sample, 13.8% of reproductive-age women reported a history of infertility, of whom 40% did not access health care. Self-reported PID was associated with infertility, especially in young women. Annual chlamydia and gonorrhea screening to avert PID may reduce the burden of infertility in the United States.

Entities:  

Mesh:

Year:  2019        PMID: 31194716      PMCID: PMC6579036          DOI: 10.1097/OLQ.0000000000000996

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  15 in total

1.  Diverging fertility among U.S. women who delay childbearing past age 30.

Authors:  S P Martin
Journal:  Demography       Date:  2000-11

Review 2.  Risk of sequelae after Chlamydia trachomatis genital infection in women.

Authors:  Catherine L Haggerty; Sami L Gottlieb; Brandie D Taylor; Nicola Low; Fujie Xu; Roberta B Ness
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 3.  Psychological impact of infertility.

Authors:  Tara M Cousineau; Alice D Domar
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2007-01-22       Impact factor: 5.237

4.  Infertility trends among U.S. couples: 1965-1976.

Authors:  W D Mosher
Journal:  Fam Plann Perspect       Date:  1982 Jan-Feb

5.  Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus.

Authors:  Prashini Moodley; David Wilkinson; Cathy Connolly; Jack Moodley; A Willem Sturm
Journal:  Clin Infect Dis       Date:  2002-01-07       Impact factor: 9.079

6.  Trends in pelvic inflammatory disease emergency department visits, United States, 2006-2013.

Authors:  Kristen Kreisel; Elaine W Flagg; Elizabeth Torrone
Journal:  Am J Obstet Gynecol       Date:  2017-10-16       Impact factor: 8.661

7.  Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.

Authors:  Pippa Oakeshott; Sally Kerry; Adamma Aghaizu; Helen Atherton; Sima Hay; David Taylor-Robinson; Ian Simms; Phillip Hay
Journal:  BMJ       Date:  2010-04-08

8.  Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis.

Authors:  W E Stamm; M E Guinan; C Johnson; T Starcher; K K Holmes; W M McCormack
Journal:  N Engl J Med       Date:  1984-03-01       Impact factor: 91.245

9.  Trends in Pelvic Inflammatory Disease Among American Indian and Alaska Native Women, Indian Health Service, 2001-2015.

Authors:  Andria Apostolou; Christina Chapman; Marissa Person; Kristen Kreisel; Jeffrey McCollum
Journal:  Am J Public Health       Date:  2018-09-25       Impact factor: 9.308

10.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

View more
  5 in total

1.  No association between HPV vaccination and infertility in U.S. females 18-33 years old.

Authors:  Nicholas B Schmuhl; Katherine E Mooney; Xiao Zhang; Laura G Cooney; James H Conway; Noelle K LoConte
Journal:  Vaccine       Date:  2020-04-03       Impact factor: 3.641

2.  Bacterial Vaginosis and Behavioral Factors Associated With Incident Pelvic Inflammatory Disease in the Longitudinal Study of Vaginal Flora.

Authors:  Rodman Turpin; Susan Tuddenham; Xin He; Mark A Klebanoff; Khalil G Ghanem; Rebecca M Brotman
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 7.759

3.  Racial, Ethnic, and Geographic Disparities in Cardiovascular Health Among Women of Childbearing Age in the United States.

Authors:  Yi Zheng; Xiaoxiao Wen; Jiang Bian; Jinying Zhao; Heather S Lipkind; Hui Hu
Journal:  J Am Heart Assoc       Date:  2021-08-25       Impact factor: 5.501

4.  Chlamydia infection, PID, and infertility: further evidence from a case-control study in China.

Authors:  Lijun Liu; Changchang Li; Xuewan Sun; Jie Liu; Hepeng Zheng; Bin Yang; Weiming Tang; Cheng Wang
Journal:  BMC Womens Health       Date:  2022-07-15       Impact factor: 2.742

5.  Effectiveness and safety of morinidazole in the treatment of pelvic inflammatory disease: A multicenter, prospective, open-label phase IV trial.

Authors:  Ting Zhou; Ming Yuan; Pengfei Cui; Jingjing Li; Feifei Jia; Shixuan Wang; Ronghua Liu
Journal:  Front Med (Lausanne)       Date:  2022-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.